The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Osteoblastic cells regulate the haematopoietic stem cell niche
Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Divieti, P., Bringhurst, F. R., et al. (2003) · Nature · doi:10.1038/nature02040 · Cited by 3,455
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294 · cited 1×
“They occur more frequently in postmenopausal women and men at sites enriched in cancellous bone, such as the vertebrae and femoral neck [64, 65].”
BackgroundAlendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationIncreased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969 · cited 1×
“11β-hydroxysteroid dehydrogenases regulate the interconversion between cortisone and hormonally active cortisol, and play a role in the regulation of glucocorticoid activity [72].”
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Wnt signaling in osteoblasts and bone diseases
Westendorf, J. J., Kahler, R. A., & Schroeder, T. M. (2004) · Gene · doi:10.1016/j.gene.2004.06.044 · Cited by 808
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794 · cited 1×
“Glucocorticoids increase the expression of M-CSF and RANK-L, and decrease the expression of its soluble decoy receptor, osteoprotegerin, in stromal and osteoblastic cells [30, 31].”
BackgroundO’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771
Freije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., & López-Otín, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89457-7 · Cited by 762
Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation
Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17124 · Cited by 747
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5 · Cited by 647
Cohen, S., Levy, R. M., Keller, M., Boling, E., Emkey, R. D., Greenwald, M., Zizic, T. M., Wallach, S., Sewell, K. L., Lukert, B. P., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2309::aid-anr8>3.0.co;2-k · Cited by 613
Wu, Z., Bucher, N. L. R., & Farmer, S. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4128 · Cited by 605
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
Staa, T. P. V., Geusens, P., Bijlsma, J. W. J., Leufkens, H. G. M., & Cooper, C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22117 · Cited by 587 · cited 1×
“This recommendation is consistent with data demonstrating that fracture risk is highest during the time of glucocorticoid exposure [104].”
BackgroundEssential role of β-catenin in postnatal bone acquisition.
Holmen, S. L., Zylstra, C. R., Mukherjee, A., Sigler, R. E., Faugere, M.-C., Bouxsein, M. L., Deng, L., Clemens, T. L., & Williams, B. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501900200 · Cited by 584
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559 · cited 1×
“It is likely to be different from that established in postmenopausal osteoporosis because fractures in GIO occur at higher BMDs [83] (Fig.”
BackgroundCanalis, E., Centrella, M., Burch, W., & McCarthy, T. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113885 · Cited by 543
Self-citationLane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., & Arnaud, C. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3914 · Cited by 529
Wallach, S., Cohen, S., Reid, D. M., Hughes, R. A., Hosking, D. J., Laan, R. F., Doherty, S. M., Maricic, M., Rosen, C., Brown, J., et al. (2000) · Calcified Tissue International · doi:10.1007/s002230001146 · Cited by 513
Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
Schwartz, A. V., Sellmeyer, D. E., Vittinghoff, E., Palermo, L., Lecka-Czernik, B., Feingold, K. R., Strotmeyer, E. S., Resnick, H. E., Carbone, L., Beamer, B. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2226 · Cited by 500
The Vitamin D requirement in health and disease
Heaney, R. P. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.06.020 · Cited by 418
Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density
Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2006) · Endocrinology · doi:10.1210/en.2006-0459 · Cited by 394
Glucocorticoids suppress bone formation via the osteoclast.
Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384 · cited 2×
“The direct effects of glucocorticoids on osteoclasts also may contribute to an operational decline in osteoblast function during glucocorticoid exposure [35].”
BackgroundAngeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., & Giustina, A. (2006) · Bone · doi:10.1016/j.bone.2006.02.005 · Cited by 365
Self-citationGlucocorticoid-induced osteoporosis: an update
Mazziotti, G., Angeli, A., Bilezikian, J. P., Canalis, E., & Giustina, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.009 · Cited by 362
Self-citationLane, N. E., Yao, W., Balooch, M., Nalla, R. K., Balooch, G., Habelitz, S., Kinney, J. H., & Bonewald, L. F. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051103 · Cited by 355
Van Rossum, E. F. C., Koper, J. W., Van Den Beld, A. W., Uitterlinden, A. G., Arp, P., Ester, W., Janssen, J. A. M. J. L., Brinkmann, A. O., De Jong, F. H., Grobbee, D. E., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01888.x · Cited by 315
Buckley, L. M., Leib, E. S., Cartularo, K. S., Vacek, P. M., & Cooper, S. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00004 · Cited by 310
Does a Fracture at One Site Predict Later Fractures at Other Sites? A British Cohort Study
van Staa, T. P., van Staa, T. P., van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200084 · Cited by 291
Myostatin Gene Deletion Prevents Glucocorticoid-Induced Muscle Atrophy
Gilson, H., Schakman, O., Combaret, L., Lause, P., Grobet, L., Attaix, D., Ketelslegers, J. M., & Thissen, J. P. (2007) · Endocrinology · doi:10.1210/en.2006-0539 · Cited by 278
Oral glucocorticoid use is associated with an increased risk of fracture
Steinbuch, M., Youket, T. E., & Cohen, S. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1548-3 · Cited by 277
Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts
Ohnaka, K., Tanabe, M., Kawate, H., Nawata, H., & Takayanagi, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.117 · Cited by 270
The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis
van Staa, T. P. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0019-1 · Cited by 260
Perspectives on glucocorticoid-induced osteoporosis
Canalis, E., Bilezikian, J. P., Angeli, A., & Giustina, A. (2004) · Bone · doi:10.1016/j.bone.2003.11.026 · Cited by 249
Self-citationThe C/EBP Family of Transcription Factors
Wedel, A., & Lömsziegler-Heitbrock, H. W. (1995) · Immunobiology · doi:10.1016/s0171-2985(11)80541-3 · Cited by 248
CANALIS, E. (1983) · Endocrinology · doi:10.1210/endo-112-3-931 · Cited by 241
Self-citationDempster, D. W., Arlot, M. A., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 233
Cooper, M. S., Bujalska, I., Rabbitt, E., Walker, E. A., Bland, R., Sheppard, M. C., Hewison, M., & Stewart, P. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1037 · Cited by 227
The Risk of Osteoporosis in Caucasian Men and Women with Obstructive Airways Disease
Sin, D. D., Man, J. P., & Man, S. F. P. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01297-4 · Cited by 225
Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis
de Nijs, R. N. J., Jacobs, J. W. G., Lems, W. F., Laan, R. F. J., Algra, A., Huisman, A.-M., Buskens, E., de Laet, C. E. D., Oostveen, A. C. M., Geusens, P. P. M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053569 · Cited by 208
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Russcher, H., Smit, P., van den Akker, E. L. T., van Rossum, E. F. C., Brinkmann, A. O., de Jong, F. H., Lamberts, S. W. J., & Koper, J. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0646 · Cited by 199
Lunt, M., Felsenberg, D., Reeve, J., Benevolenskaya, L., Cannata, J., Dequeker, J., Dodenhof, C., Falch, J. A., Masaryk, P., Pols, H. A. P., et al. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1883 · Cited by 194
Rubin, M. R., & Bilezikian, J. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-012101 · Cited by 193
Self-citationOsteoporosis after solid organ and bone marrow transplantation
Cohen, A., & Shane, E. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1426-z · Cited by 193
Bonadonna, S., Mazziotti, G., Nuzzo, M., Bianchi, A., Fusco, A., De Marinis, L., & Giustina, A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050603 · Cited by 188
Self-citationPereira, R. C., Delany, A. M., & Canalis, E. (2002) · Bone · doi:10.1016/s8756-3282(02)00687-7 · Cited by 165
Self-citationSmith, E., & Frenkel, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m406294200 · Cited by 165
van Rossum, E. F. C., Voorhoeve, P. G., te Velde, S. J., Koper, J. W., Delemarre-van de Waal, H. A., Kemper, H. C. G., & Lamberts, S. W. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031422 · Cited by 164
Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update
Boonen, S., Vanderschueren, D., Haentjens, P., & Lips, P. T. A. M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01655.x · Cited by 161
Mechanisms of glucocorticoid action in bone
Canalis, E. (2005) · Current Osteoporosis Reports · doi:10.1007/s11914-005-0017-7 · Cited by 159
Self-citationIs bone mineral density predictive of fracture risk reduction?
Cefalu, C. A. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003062 · Cited by 156
Prevention of Glucocorticoid-Induced Apoptosis in Osteocytes and Osteoblasts by Calbindin-D28k
Liu, Y., Porta, A., Peng, X., Gengaro, K., Cunningham, E. B., Li, H., Dominguez, L. A., Bellido, T., & Christakos, S. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301242 · Cited by 153
Delany, A. M., Gabbitas, B., & CANALIS, E. M. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570314 · Cited by 153
Self-citationShiraishi, A., Takeda, S., Masaki, T., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.770 · Cited by 151
Eijken, M., Koedam, M., van Driel, M., Buurman, C. J., Pols, H. A. P., & van Leeuwen, J. P. T. M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.034 · Cited by 147
Mazziotti, G., Bianchi, A., Bonadonna, S., Nuzzo, M., Cimino, V., Fusco, A., De Marinis, L., & Giustina, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060112 · Cited by 141
Self-citationOkazaki, R., Riggs, B. L., & Conover, C. A. (1994) · Endocrinology · doi:10.1210/endo.134.1.7506203 · Cited by 140
Practice patterns in patients at risk for glucocorticoid-induced osteoporosis
Feldstein, A. C., Elmer, P. J., Nichols, G. A., & Herson, M. (2005) · Osteoporosis International · doi:10.1007/s00198-005-2016-z · Cited by 132
C/EBP Regulates Hepatic Transcription of 11β-Hydroxysteroid Dehydrogenase Type 1
Williams, L. J. S., Lyons, V., MacLeod, I., Rajan, V., Darlington, G., Poli, V., Seckl, J. R., & Chapman, K. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001286200 · Cited by 130
Amin, S., LaValley, M. P., Simms, R. W., & Felson, D. T. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1512 · Cited by 127
Natsui, K., Tanaka, K., Suda, M., Yasoda, A., Sakuma, Y., Ozasa, A., Ozaki, S., & Nakao, K. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1923-3 · Cited by 126
de Nijs, R. N. J., Jacobs, J. W. G., Algra, A., Lems, W. F., & Bijlsma, J. W. J. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1614-5 · Cited by 124
Delany, A. M., Jeffrey, J. J., Rydziel, S., & CANALIS, E. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26607 · Cited by 121
Self-citationRehman, Q., Lang, T., Arnaud, C. D., Modin, G. W., & Lane, N. E. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1312-0 · Cited by 118
Osteoporosis Associated with Excess Glucocorticoids
Shaker, J. L., & Lukert, B. P. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.014 · Cited by 115
Huybers, S., Naber, A. H. J., Bindels, R. J. M., & Hoenderop, J. G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00317.2006 · Cited by 115
Ito, S., Suzuki, N., Kato, S., Takahashi, T., & Takagi, M. (2006) · Bone · doi:10.1016/j.bone.2006.07.012 · Cited by 114
Rubin, J., Biskobing, D. M., Jadhav, L., Fan, D., Nanes, M. S., Perkins, S., & Fan, X. (1998) · Endocrinology · doi:10.1210/endo.139.3.5778 · Cited by 113 · cited 1×
“Glucocorticoids increase the expression of M-CSF and RANK-L, and decrease the expression of its soluble decoy receptor, osteoprotegerin, in stromal and osteoblastic cells [30, 31].”
Background詫摩, 敦., Kaneda, T., Sato, T., Ninomiya, S., Kumegawa, M., & Hakeda, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300213200 · Cited by 113
Laan, R., Buijs, W. C. A. M., van Erning, L. J. T. O., Lemmens, J. A. M., Corstens, F. H. M., Ruijs, S. H. J., van de Putte, L. B. A., & van Riel, P. L. C. M. (1993) · Calcified Tissue International · doi:10.1007/bf00675619 · Cited by 111
Lane, N. E., Sanchez, S., Genant, H. K., Jenkins, D. K., & Arnaud, C. D. (2000) · Osteoporosis International · doi:10.1007/s001980070111 · Cited by 109
CCAAT/Enhancer Binding Protein Homologous Protein (DDIT3) Induces Osteoblastic Cell Differentiation
Pereira, R. C., Delany, A. M., & CANALIS, E. M. (2003) · Endocrinology · doi:10.1210/en.2003-0868 · Cited by 99
Self-citationBone Structure in Patients with Low Bone Mineral Density With or Without Vertebral Fractures
Oleksik, A. M., Ott, S. M., Vedi, S., Bravenboer, N., Compston, J. E., & Lips, P. T. A. M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.7.1368 · Cited by 98
Ureña, P., Iida‐Klein, A., Kong, X. F., Jüppner, H., Kronenberg, H. M., Abou‐Samra, A., & Segre, G. V. (1994) · Endocrinology · doi:10.1210/en.134.1.451 · Cited by 97
Devlin, R. D., Du, Z., Buccilli, V., Jorgetti, V., & CANALIS, E. M. (2002) · Endocrinology · doi:10.1210/en.2002-220129 · Cited by 95
Self-citationImmunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins
Ohmori, H., & Kanayama, N. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.11.011 · Cited by 94
Giustina, A., Bussi, A. R., Jacobello, C., & Wehrenberg, W. B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.1.7829600 · Cited by 90
Self-citationBaylink, D. J., & Wergedal, J. E. (1971) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1971.221.3.669 · Cited by 86
Bonadonna, S., Burattin, A., Nuzzo, M., Bugari, G., Rosei, E. A., Valle, D., Iori, N., Bilezikian, J. P., Veldhuis, J. D., & Giustina, A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01841 · Cited by 85
Self-citationBone histomorphometry and structure in corticosteroid treated chronic active hepatitis.
Stellon, A. J., Webb, A., & Compston, J. E. (1988) · Gut · doi:10.1136/gut.29.3.378 · Cited by 83
Sher, L. B., Harrison, J. R., Adams, D. J., & Kream, B. E. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0297-z · Cited by 80
Buxton, E. C., Yao, W., & Lane, N. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032066 · Cited by 79 · cited 1×
“According to the concept of the “anabolic window”, PTH rapidly and powerfully stimulates osteoblast function [112].”
BackgroundSkeletal morbidity in inflammatory bowel disease
van Hogezand, R. A., & Hamdy, N. A. T. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520600664276 · Cited by 79
Gabbitas, B., Pash, J. M., Delany, A. M., & CANALIS, E. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.9033 · Cited by 75
Self-citationSamuels, M. H., Veldhuis, J. D., Cawley, C., Urban, R. J., Luther, M., Bauer, R. L., & Mundy, G. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.399 · Cited by 67
Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets
Eizirik, D. L., Welsh, N., & Hellerström, C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.399 · Cited by 66
Trends in prevention of glucocorticoid-induced osteoporosis.
Saag, K. G., Gehlbach, S. H., Curtis, J. R., Youket, T. E., Worley, K., & Lange, J. L. (2006) · PubMed · Cited by 63
Lekamwasam, S., Trivedi, D. P., & Khaw, K. (2002) · Osteoporosis International · doi:10.1007/s001980200097 · Cited by 58
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates
Romas, E. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.06.008 · Cited by 58
Clinical utility of microarchitecture measurements of trabecular bone
Carballido‐Gamio, J., & Majumdar, S. (2006) · Current Osteoporosis Reports · doi:10.1007/s11914-006-0004-7 · Cited by 57
US and UK guidelines for glucocorticoid-induced osteoporosis: Similarities and differences
Compston, J. E. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0085-1 · Cited by 55
Giustina, A., Bossoni, S., Bodini, C., Girelli, A., Balestrieri, G. P., Pizzocolo, G., & Wehrenberg, W. B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1592874 · Cited by 54
Self-citationDovio, A., Perazzolo, L., Saba, L., Termine, A., Capobianco, M. A. N., Bertolotto, A., & Angeli, A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02147 · Cited by 46
Standards for Performing DXA in Individuals With Secondary Causes of Osteoporosis
Khan, A. A., Hanley, D. A., Bilezikian, J. P., Binkley, N., Brown, J. P., Hodsman, A. B., Josse, R. G., Kendler, D. L., Lewiecki, E. M., Miller, P. D., et al. (2006) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2006.01.001 · Cited by 44
Self-citationSchacht, E. (1999) · Calcified Tissue International · doi:10.1007/s002239900705 · Cited by 43
Malerba, M., Bossoni, S., Radaeli, A., Mori, E., Bonadonna, S., Giustina, A., & Tantucci, C. (2005) · CHEST Journal · doi:10.1378/chest.127.2.515 · Cited by 40
Self-citationManagement of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease
Franchimont, N., & CANALIS, E. M. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00056-9 · Cited by 39
Self-citationPrevalence of Evaluation and Treatment of Glucocorticoid-Induced Osteoporosis in Men
Cruse, L. M., Valeriano, J., Vasey, F. B., & Carter, J. D. (2006) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000242778.65766.22 · Cited by 37
Cortisol represses insulin-like growth factor II receptor transcription in skeletal cell cultures
Rydziel, S., & CANALIS, E. M. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664643 · Cited by 34
Self-citationAlendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis
de Nijs, R. N. J., Jacobs, J. W. G., Lems, W. F., Laan, R., Algra, A., Huisman, A.-M., Buskens, E., Laet, C. E. D. H. D., Oostveen, A. C. M., Geusens, P., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000251010.34115.0a · Cited by 34
Growth Hormone in Glucocorticoid-Induced Osteoporosis
Manelli, F., Carpinteri, R., Bossoni, S., Burattin, A., Bonadonna, S., Rosei, E. A., & Giustina, A. (2002) · KARGER eBooks · doi:10.1159/000061083 · Cited by 31
Self-citationSamuels, M. H., Veldhuis, J. D., Kramer, P. F., Urban, R. J., Bauer, R. L., & Mundy, G. R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.4.616 · Cited by 26
Body composition and vertebral fracture risk in female patients treated with glucocorticoid
Kaji, H., Tobimatsu, T., Naito, J., Iu, M.-F., Yamauchi, M., Sugimoto, T., & Chihara, K. (2005) · Osteoporosis International · doi:10.1007/s00198-005-0026-5 · Cited by 22
Active acromegaly enhances spontaneous parathyroid hormone pulsatility
Mazziotti, G., Cimino, V., Menis, E. D., Bonadonna, S., Bugari, G., Marinis, L. D., Veldhuis, J. D., & Giustina, A. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.009 · Cited by 17
Self-citationIu, M.-F., Kaji, H., Naito, J., Sowa, H., Sugimoto, T., & Chihara, K. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0627-2 · Cited by 10
[Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].
Masaki, H., & Miki, T. (2006) · PubMed · Cited by 9
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Cited by
Feng, X., & McDonald, J. M. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130203 · Cited by 1,272
Khosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Self-citationGlucocorticoid-Induced Bone Disease
Weinstein, R. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1012926 · Cited by 694
Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Metadata
- Authors
- Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P.
- Venue
- Osteoporosis International
- Published
- 2007-06-14
- Volume
- 18
- Issue
- 10
- Pages
- 1319-1328
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2171133944
- Cited by
- 1,114
- References
- 115
- FWCI
- 42.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.